Fetal Alcohol Syndrome Clinical Trial
Official title:
A Study of the Efficacy of Atomoxetine in Treating the Inattention, Impulsivity and Hyperactivity in Children With Fetal Alcohol Syndrome or Effects
The purpose of this study is to determine if atomoxetine hydrochloride improves inattention, hyperactivity, and impulsivity problems in children exposed to alcohol during birth.
Abnormalities of attention, function, and activity level in children exposed to alcohol in utero share similarities and differences to children who do not have alcohol exposure. Previous psychological studies have examined either core attention deficit hyperactivity disorder (ADHD)symptoms of hyperactivity, inattention, and impulsivity or hypothesized neuropsychological differences in children with fetal alcohol syndrome (FAS) and ADHD. Atomoxetine Hydrochloride is a non-stimulant medication used to treat ADHD. This study will determine if atomoxetine HCL significantly reduces symptoms of ADD/ADHD in children with fetal alcohol exposure. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
| Active, not recruiting |
NCT00996528 -
Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)
|
Phase 3 | |
| Completed |
NCT00164229 -
Fetal Alcohol Syndrome: Socio-Cognitive Habilitation
|
Phase 1/Phase 2 | |
| Completed |
NCT00164554 -
Fetal Alcohol Syndrome/ARND Research Consortion
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05534568 -
The Oklahoma Parent-Child Assistance Program
|
N/A | |
| Recruiting |
NCT05385328 -
Multisensorial Analysis of Human Activity for Diagnosis and Early Detection of Functional Limitations
|
||
| Completed |
NCT01911299 -
Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders
|
Phase 2 | |
| Terminated |
NCT00747630 -
Evaluating the Efficacy of a Video Based Intervention to Educate Teen Moms About Fetal Alcohol Syndrome (FAS)
|
Phase 0 | |
| Recruiting |
NCT04332172 -
Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy
|
N/A | |
| Completed |
NCT00696085 -
Fetal Alcohol Damage Prevention Study
|
N/A | |
| Recruiting |
NCT00418262 -
Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD
|
Phase 3 | |
| Completed |
NCT01149538 -
Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03371641 -
In Utero Alcoholic Exposure: PlGF, Biomarker of Fetal Brain Lesions
|
N/A | |
| Completed |
NCT00164346 -
Neurocognitive Habilitation for Children With Fetal Alcohol Syndrome (FAS)/Alcohol-Related Neurodevelopmental Disorder (ARND)
|
Phase 1/Phase 2 | |
| Completed |
NCT01994603 -
Expansion to Interdisciplinary HIV Prevention in Women
|
N/A | |
| Completed |
NCT02600624 -
Prenatal Alcohol Biomarker Study in Uruguay
|
||
| Completed |
NCT00244062 -
Healthy Moms Alcohol Intervention
|
N/A | |
| Recruiting |
NCT04395196 -
RCT of Prenatal Choline Supplementation During Pregnancy to Mitigate Adverse Effects of Prenatal Alcohol Exposure
|
Phase 2 |